Diaphragm hernia after debulking surgery in patients with ovarian cancer

被引:3
|
作者
Ehmann, Sarah [1 ]
Aviki, Emeline M. [1 ,2 ]
Sonoda, Yukio [1 ,2 ]
Boerner, Thomas [1 ]
Sassine, Dib [1 ]
Jones, David R. [2 ,3 ]
Park, Bernard [2 ,3 ]
Cohen, Murray [4 ]
Rosenblum, Norman G. [4 ]
Chi, Dennis S. [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, 1275 York Ave, New York, NY 10065 USA
[2] Cornell Univ, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA
[4] Thomas Jefferson Univ Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19107 USA
来源
GYNECOLOGIC ONCOLOGY REPORTS | 2021年 / 36卷
关键词
Diaphragmatic hernia; Ovarian cancer; Debulking surgical procedures; Postoperative complications; CYTOREDUCTIVE SURGERY; PERITONECTOMY; SPLENECTOMY; HIPEC; TIME;
D O I
10.1016/j.gore.2021.100759
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Over 80% of patients with epithelial ovarian cancer present with advanced disease, FIGO stage III or IV at the time of diagnosis. The majority require extensive upper abdominal surgery to obtain complete gross resection. This may include splenectomy, distal pancreatectomy, partial hepatectomy, cholecystectomy, and usually diaphragmatic peritonectomy or resection. Following surgery, diaphragmatic hernia-a very rare but serious complication-may occur. We describe four cases of left-sided diaphragmatic hernia resulting after debulking surgery, which included left diaphragm peritonectomy and splenectomy, in patients with advanced ovarian cancer. In association with the current shift towards more extensive debulking surgery for ovarian cancer, more patients may present with postoperative left-sided diaphragm hernia, making the prevention, diagnosis, and management of this complication important to practicing gynecologic oncologists. Intraoperatively the diaphragm should be checked thoroughly to rule out any defects, which should be closed. A diaphragmatic hernia may be easily misdiagnosed because the patient can present with various symptoms. While rare, these hernias require prompt identification, intervention and surgical correction to avoid serious complications.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer
    Rutten, M. J.
    Boldingh, J. H. L.
    Schuit, E.
    Trum, H.
    van Driel, W.
    Mol, B. W. J.
    Kenter, G. G.
    Buist, M. R.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (01) : 13 - 18
  • [42] Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer
    Lee, Jessica
    Curtin, John P.
    Muggia, Franco M.
    Pothuri, Bhavana
    Boyd, Leslie R.
    Blank, Stephanie V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) : 55 - 63
  • [43] Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
    Sorensen, Sarah Mejer
    Hogdall, Claus
    Mosgaard, Berit Jul
    Dalgaard, Maya Isabella Riise
    Jensen, Mai Partridge
    Fuglsang, Katrine
    Schnack, Tine Henrichsen
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2022, 101 (03) : 334 - 343
  • [44] Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer
    Jessica Lee
    John P. Curtin
    Franco M. Muggia
    Bhavana Pothuri
    Leslie R. Boyd
    Stephanie V. Blank
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 55 - 63
  • [45] Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism
    Filippova, Olga T.
    Kim, Sun Woo
    Cowan, Renee A.
    Chi, Andrew J.
    Iasonos, Alexia
    Zhou, Qin C.
    Broach, Vance
    Zivanovic, Oliver
    Roche, Kara Long
    Sonoda, Yukio
    Gardner, Ginger
    Chi, Dennis S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (08) : 1183 - 1188
  • [46] Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer
    Torres, Diogo
    Kumar, Amanika
    Bakkum-Gamez, Jamie N.
    Weaver, Amy L.
    McGree, Michaela E.
    Wang, Chen
    Langstraat, Carrie L.
    Cliby, William A.
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 223 - 227
  • [47] CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Furukawa, Naoto
    Sasaki, Yoshikazu
    Shigemitsu, Aiko
    Akasaka, Juria
    Kanayama, Seiji
    Kawaguchi, Ryuji
    Kobayashi, Hiroshi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (02) : 141 - 145
  • [48] Gastric Volvulus: A Delayed Surgical Complication After Debulking and Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
    Ghattas, Souad
    Maalouf, Hani
    Hadeer, Ribal Aby
    Elias, Fawzi
    Abou Zeid, Hadi Khaled
    Kahy, Anthony
    Wakim, Raja
    ACG CASE REPORTS JOURNAL, 2023, 10 (02)
  • [49] After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer A National Cancer Database Study
    Seagle, Brandon-Luke L.
    Graves, Stephen
    Strohl, Anna E.
    Shahabi, Shohreh
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1610 - 1618
  • [50] Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis
    Ghirardi, V
    Moruzzi, M. C.
    Bizzarri, N.
    Vargiu, V.
    D'Indinosante, M.
    Garganese, G.
    Pasciuto, T.
    Loverro, M.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 209 - 213